Cancer Treatment

Oral Cancer: Current Treatments and Future Progress

6 min read
Image of lungs

Oral Cancer: Current Treatments and Future Progress

Oral cancer is a type of cancer that affects various parts of the mouth, including the lips, tongue, gums, floor of the mouth, and the soft and hard palate. It is a serious and potentially life-threatening disease that requires immediate medical attention. In this article, we will discuss the epidemiology, diagnosis, and treatment options for oral cancer, with a focus on the current drugs used and promising future drugs in late-stage clinical trials.

Epidemiology of Oral Cancer

Oral cancer is a global health issue, with an estimated 354,864 new cases and 177,384 deaths reported in 2020 alone. It predominantly affects individuals over the age of 45, with men being twice as likely to develop oral cancer compared to women. Tobacco use, both smoking and smokeless, is considered a significant risk factor for oral cancer. Additionally, excessive alcohol consumption, poor oral hygiene, and certain viral infections, such as human papillomavirus (HPV), can increase the risk of developing oral cancer.

Diagnosis of Oral Cancer

The diagnosis of oral cancer typically involves a thorough examination of the mouth and surrounding tissues by a healthcare professional. This may include a physical inspection, palpation of the neck and oral cavity, and additional diagnostic tests. Biopsy, where a small tissue sample is collected and examined under a microscope, is often necessary to confirm the presence of cancer cells. Imaging techniques such as X-rays, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans may also be used to determine the extent of the disease.

Treatment of Oral Cancer

The treatment approach for oral cancer depends on various factors, including the stage of the cancer, the location and size of the tumor, and the individual's overall health. The main treatment modalities for oral cancer include surgery, radiation therapy, and chemotherapy. Often, a combination of these treatments is used to achieve the best possible outcome.

Surgery: Surgical removal of the tumor is a common treatment option for oral cancer. The extent of surgery may range from a minor procedure to remove a small lesion to a more extensive operation involving the removal of a portion of the jaw or tongue. In some cases, reconstructive surgery may be required to restore the appearance and functionality of the affected areas.

Radiation Therapy: Radiation therapy utilizes high-energy beams to kill cancer cells and shrink tumors. It can be administered externally or internally, depending on the specific situation. Radiation therapy is often used before or after surgery to enhance the effectiveness of treatment, or as the primary treatment for cases where surgery is not feasible.

Chemotherapy: Chemotherapy involves the use of drugs to kill cancer cells throughout the body. It is typically used in advanced cases of oral cancer or in combination with surgery and/or radiation therapy. Chemotherapy drugs may be administered orally or intravenously, and they work by targeting rapidly dividing cells, including cancer cells.

Current Drugs Used to Treat Oral Cancer

Several drugs have been approved for the treatment of oral cancer and are currently used in clinical practice. These drugs target specific molecular pathways involved in cancer growth and survival.

  • Cisplatin: Cisplatin is a chemotherapy drug that works by damaging the DNA of cancer cells, preventing their replication and growth. It is often used in combination with other chemotherapy drugs or radiation therapy for the treatment of oral cancer.
  • Fluorouracil (5-FU): 5-FU is another chemotherapy drug that interferes with the replication process of cancer cells. It is commonly used in combination with cisplatin or other drugs for the treatment of oral cancer.
  • Cetuximab: Cetuximab is a targeted therapy drug that specifically inhibits the activity of the epidermal growth factor receptor (EGFR). EGFR is often overexpressed in oral cancer cells, and by blocking its activity, cetuximab can slow down tumor growth.
  • Docetaxel: Docetaxel is a chemotherapy drug that disrupts the microtubule structures within cells, preventing their proper function and division. It may be used as a treatment option for advanced or recurrent oral cancer.
  • Paclitaxel: Paclitaxel, like docetaxel, interferes with cell division by targeting microtubules. It is commonly used in combination with other drugs for the treatment of oral cancer.

Promising Future Drugs in Late-Stage Clinical Trials

There are several promising drugs currently in late-stage clinical trials for the treatment of oral cancer. While their full potential is yet to be realized, initial results have shown encouraging efficacy and safety profiles.

  • Opdivo (Nivolumab): Opdivo is an immune checkpoint inhibitor that enhances the body's immune response against cancer cells. Clinical trials have shown promising results in the treatment of various cancers, including advanced oral cancer.
  • Keytruda (Pembrolizumab): Keytruda is another immune checkpoint inhibitor that has demonstrated significant clinical benefit in the treatment of advanced oral cancer. It helps the immune system recognize and attack cancer cells more effectively.
  • Talazoparib: Talazoparib is a poly (ADP-ribose) polymerase (PARP) inhibitor currently being evaluated in clinical trials for the treatment of oral cancer. PARP inhibitors target specific DNA repair processes within cancer cells, leading to their demise.
  • Tucatinib: Tucatinib is a tyrosine kinase inhibitor that selectively inhibits HER2, a protein that promotes the growth of cancer cells. Clinical trials are ongoing to assess its effectiveness in the treatment of HER2-positive oral cancer.
  • Trilaciclib: Trilaciclib is a novel drug that aims to protect bone marrow cells from chemotherapy-induced damage, reducing the severity of side effects and potentially allowing for higher doses of chemotherapy to be administered. It is being studied in combination with chemotherapy for the treatment of oral cancer.

In conclusion, oral cancer is a complex and challenging disease that requires a multidisciplinary approach for effective management. Current treatment options such as surgery, radiation therapy, and chemotherapy have shown varying degrees of success. However, ongoing research and clinical trials offer hope for the development of new and improved drugs to further enhance outcomes for patients with oral cancer. As the field of oral cancer trials continues to evolve, it is crucial to stay informed and explore the potential of these promising future drugs.